|
|||||
|
|
Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab |
|
| Authors: | Paul M Ridker Lynda M. Rose John J.P. Kastelein Raul D. Santos Caimiao Wei James Revkin Carla Yunis Jean-Claude Tardif Charles L. Shear |
| Affiliation: | 1. Brigham and Women''s Hospital, Harvard Medical School, Boston, MA, USA;2. Academic Medical Center of the University of Amsterdam, Amsterdam, Netherlands;3. Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital, São Paulo, Brazil;4. Pfizer Inc., New York, NY, USA;5. Montreal Heart Institute, Université de Montréal, Montreal, Canada;6. CiVi Biopharma, Philadelphia, PA |
| Abstract: | |
| Keywords: | Familial hypercholesterolemia PCSK9 inhibition Event reduction |
| 本文献已被 ScienceDirect 等数据库收录！ | |